BackGlycoMimetics Overview

GlycoMimetics Total Assets

Track GlycoMimetics's total assets ($180M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$182.76M
↑ 16.09% YoYΔ $25.32M vs prior year quarter

Peer trimmed avg / median

Loading

GlycoMimetics Total Assets History

Loading

GlycoMimetics vs. peers: Total Assets Comparison

Loading

GlycoMimetics Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

GlycoMimetics (GLYC) FAQ

GlycoMimetics (GLYC) currently reports a total assets of $180M as of June 2026. That compares with $160M in the prior-year period — up 16.1% year over year. Use the charts on this page to explore GlycoMimetics's total assets history and peer comparisons.

GlycoMimetics's total assets increased from $160M to $180M — a 16.1% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

GlycoMimetics reported $180M in total assets as of June 2026. That compares with $160M in the prior-year period — up 16.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total assets of $180M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for GlycoMimetics, and consider following GLYC for alerts when major investors trade the stock.

GlycoMimetics is classified in the Healthcare sector. On total assets, it currently shows $180M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing GLYC with unrelated industries.